MicroPort Scientific Corporation (00853.HK) Latest Company News

Sep 1, 2026, 14:54 UTC
Hang Seng Biotech ETF (E Fund) announced that due to the suspension of constituent stocks MicroPort Scientific and MicroPort MedBot from September 1, 2026, it will adjust the clearing and settlement arrangements for subscription and redemption cash substitutions for these two securities starting September 2, 2026.
Source:
- finance.sina.cn
Sep 1, 2026, 02:45 UTC
Shanghai MicroPort MedBot (Group) Co., Ltd. suspended trading on the Hong Kong Stock Exchange from September 1, 2026, due to delayed publication of its 2026 interim results pending clarification of a leasing arrangement counterparty relationship.
Source:
- aastocks.com
Aug 31, 2026, 15:03 UTC
MicroPort Scientific announced on August 31, 2026 that it will delay the publication of its interim results for the six months ended June 30, 2026, and that trading in its shares and debt securities will be suspended from September 1, 2026 pending the release of the results.
Source:
Aug 26, 2026, 15:27 UTC
MicroPort CardioFlow announced senior management changes effective August 26, 2026: Zhang Ruinian resigned as CEO and was appointed President; Chen Guoming resigned as Chairman, was re-designated from non-executive to executive director, and was appointed CEO; Brian Chang was appointed Chairman and audit committee member.
Source:
- aastocks.com
Aug 24, 2026, 04:22 UTC
Mai Ke Medicine (02335) was selected for inclusion as a constituent stock of the Hang Seng Composite Index, effective September 7, 2026.
Source:
- aastocks.com
Aug 12, 2026, 15:48 UTC
MicroPort Scientific issued a profit warning, expecting a net loss of no more than USD 50 million for the first half of 2026, compared to a net loss of USD 49 million in the same period last year.
Source:
- aastocks.com
Jul 16, 2026, 02:09 UTC
MicroPort Scientific announced that its subsidiary Suzhou MicroPort and TINAVI Medical Technologies have signed a letter of intent for TINAVI's potential acquisition of equity in Shanghai MicroPort Orthopedic Medical Technology, with consideration to be paid in new TINAVI shares.
Source:

00853.HK

Shanghai MicroPort MedBot (Group) Co., Ltd. suspended trading on the Hong Kong Stock Exchange from September 1, 2026, due to delayed publication of its 2026 interim results pending clarification of a leasing arrangement counterparty relationship.

MicroPort Scientific announced on August 31, 2026 that it will delay the publication of its interim results for the six months ended June 30, 2026, and that trading in its shares and debt securities will be suspended from September 1, 2026 pending the release of the results.

Mai Ke Medicine (02335) was selected for inclusion as a constituent stock of the Hang Seng Composite Index, effective September 7, 2026.

MicroPort Scientific issued a profit warning, expecting a net loss of no more than USD 50 million for the first half of 2026, compared to a net loss of USD 49 million in the same period last year.

MicroPort Scientific announced that its subsidiary Suzhou MicroPort and TINAVI Medical Technologies have signed a letter of intent for TINAVI's potential acquisition of equity in Shanghai MicroPort Orthopedic Medical Technology, with consideration to be paid in new TINAVI shares.